Properties (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Custom Manufacturing
|
| gptkbp:hasAmenities |
gptkb:ISO_9001
gptkb:ISO_13485 FDA_Approval EMA_Approval |
| gptkbp:hasEmployees |
Over 15,000
|
| gptkbp:hasExhibition |
Monoclonal Antibodies
Vaccine Production Small Molecules Large Molecules |
| gptkbp:hasLocation |
gptkb:Singapore
gptkb:Switzerland gptkb:United_States |
| gptkbp:hasPartnershipsWith |
Academic Institutions
Pharmaceutical Companies Research Organizations Biotech_Companies |
| gptkbp:hasResidence |
Over $5 billion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lonza Custom Manufacturing
|
| gptkbp:isFocusedOn |
gptkb:Swiss_Stock_Exchange
|
| gptkbp:isHeadquarteredIn |
gptkb:Basel,_Switzerland
|
| gptkbp:isInvolvedIn |
Clinical Trials
Product Development Regulatory Submissions Commercial Production |
| gptkbp:isKnownFor |
Flexibility
Scalability Quality Assurance Regulatory Compliance Sustainability Initiatives Innovation in Manufacturing |
| gptkbp:isPartOf |
gptkb:Lonza_Group
|
| gptkbp:offers |
Formulation Development
Fill and Finish Services Cell and Gene Therapy Services Analytical_Services |
| gptkbp:provides |
Process Development
Manufacturing_Services Contract_Manufacturing_Services |
| gptkbp:serves |
Pharmaceutical Industry
Biotechnology Industry |
| gptkbp:specializesIn |
Biopharmaceuticals
|
| gptkbp:utilizes |
Automation
Advanced_Technologies Continuous_Manufacturing Single-Use_Technologies |
| gptkbp:wasFoundedIn |
1897
|